ARCHIVES

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

This article is from The Cancer Letter archive.

Vol. 32 No. 02 | January 20, 2006

Download PDF Visit The Full Archive

Related Articles

Daniel Hayes Elected President of ASCO

December 12, 2014

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

October 7, 1977

New Agency To Evaluate PDQ; NCAB Approves NCI Payment Of Part

June 1, 1990

In Brief: Susumu Tonegawa To Receive Bristol-Myers Award; Mark Green Named Director Of UCSD Cancer Center

March 7, 1986

NCAB To Monitor Virus Program; NCI Answers Zinder Report Criticisms

June 28, 1974

GSK Vaccine Prevents Lesions Associated With HPV

July 28, 2006